Memory immune responses and protection of chickens against a nephropathogenic infectious bronchitis virus strain by combining live heterologous and inactivated homologous vaccines

被引:11
|
作者
dos Santos, Romeu Moreira [1 ]
Fernando, Filipe Santos [1 ]
Silva Montassier, Maria de Fatima [1 ]
Silva, Ketherson Rodrigues [1 ]
Lopes, Priscila Diniz [1 ]
Pavani, Caren [1 ]
Borzi, Mariana Monezi [1 ]
Okino, Cintia Hiromi [2 ]
Montassier, Helio Jose [1 ]
机构
[1] Univ Estadual Paulista Julio de Mesquita Filho FC, Lab Virol & Immunol, Dept Vet Pathol, BR-14884900 Jaboticabal, SP, Brazil
[2] Embrapa Pecuaria Sudeste, BR-13560970 Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
avian coronavirus; cell-mediated immunity; humoral immunity; mucosal immunity; oil adjuvant; RESPIRATORY-TRACT; CHALLENGE; MUCOSAL; LESIONS; BRAZIL; VACCINATION; EMERGENCE; NEPHRITIS; GENOTYPE;
D O I
10.1292/jvms.18-0065
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
In this study, we evaluated antibody and cell-mediated immune (CMI) responses in the mucosal and systemic compartments and protection against challenge with a nephropathogenic Brazilian (BR-I) strain of infectious bronchitis virus (IBV) in chickens submitted to a vaccination regime comprising a priming dose of heterologous live attenuated Massachusetts vaccine followed by a booster dose of an experimental homologous inactivated vaccine two weeks later. This immunization protocol elicited significant increases in serum and lachrymal levels of anti-IBV IgG antibodies and upregulated the expression of CMI response genes, such as those encoding CD8 beta chain and Granzyme homolog A in tracheal and kidney tissues at 3, 7, and 11 days post-infection in the vaccinated chickens. Additionally, vaccinated and challenged chickens showed reduced viral loads and microscopic lesion counts in tracheal and kidney tissues, and their antibody and CMI responses were negatively correlated with viral loads in the trachea and kidney. In conclusion, the combination of live attenuated vaccine containing the Massachusetts strain with a booster dose of an inactivated vaccine, containing a BR-I IBV strain, confers effective protection against infection with nephropathogenic homologous IBV strain because of the induction of consistent memory immune responses mediated by IgG antibodies and TCD8 cells in the mucosal and systemic compartments of chickens submitted to this vaccination regime.
引用
收藏
页码:612 / 619
页数:8
相关论文
共 50 条
  • [41] Immune responses to modified live virus vaccines developed from classical or highly pathogenic PRRSV following challenge with a highly pathogenic PRRSV strain
    Wang, Gang
    Yu, Ying
    Zhang, Chong
    Tu, Yabin
    Tong, Jie
    Liu, Yonggang
    Chang, Yafei
    Jiang, Chenggang
    Wang, Shujie
    Zhou, En-Min
    Cai, Xuehui
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2016, 62 : 1 - 7
  • [42] Vaccination of Chicks with Live Attenuated Subtype B Avian Metapneumovirus Vaccines: Protection Against Challenge and Immune Responses Can Be Unrelated to Vaccine Dose
    Ganapathy, Kannan
    Jones, Richard Charles
    AVIAN DISEASES, 2007, 51 (03) : 733 - 737
  • [43] Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks
    Kim, Deok-Hwan
    Lee, Seung-hun
    Kim, Jiwon
    Lee, Jiho
    Jeong, Jei-hyun
    Kim, Ji-yun
    Song, Seung-un
    Lee, Hyukchae
    Cho, Andrew Y.
    Hyeon, Ji-Yeon
    Youk, Sungsu
    Song, Chang-Seon
    VACCINE, 2024, 42 (18) : 3756 - 3767
  • [44] Lineage 1 Porcine Reproductive and Respiratory Syndrome Virus Attenuated Live Vaccine Provides Broad Cross-Protection against Homologous and Heterologous NADC30-Like Virus Challenge in Piglets
    Zhang, Hongliang
    Xiang, Lirun
    Xu, Hu
    Li, Chao
    Tang, Yan-Dong
    Gong, Bangjun
    Zhang, Wenli
    Zhao, Jing
    Song, Shuaijie
    Peng, Jinmei
    Wang, Qian
    An, Tongqing
    Cai, Xuehui
    Tian, Zhi-Jun
    VACCINES, 2022, 10 (05)
  • [45] Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens
    Song, Byung-Min
    Kang, Hyun-Mi
    Lee, Eun-Kyoung
    Jung, Suk Chan
    Kim, Min-Chul
    Lee, Yu-Na
    Kang, Sang-Moo
    Lee, Youn-Jeong
    VACCINE, 2016, 34 (05) : 678 - 686
  • [46] TIR-TLR7 as a Molecular Adjuvant: Simultaneous Enhancing Humoral and Cell-Mediated Immune Responses Against Inactivated Infectious Bursal Disease Virus
    Ebrahimi, Mohammad Majid
    Shahsavandi, Shahla
    Shayan, Parviz
    VIRAL IMMUNOLOGY, 2019, 32 (06) : 252 - 257
  • [47] Protection Efficacy of Recombinant HVT-ND-LT and the Live Attenuated Tissue Culture Origin Vaccines Against Infectious Laryngotracheitis Virus When Administered Individually or in Combination
    Becerra, Roel
    Maekawa, Daniel
    Garcia, Maricarmen
    AVIAN DISEASES, 2023, 67 (02) : 145 - 152
  • [48] A Recombinant La Sota Vaccine Strain Expressing Multiple Epitopes of Infectious Bronchitis Virus (IBV) Protects Specific Pathogen-Free (SPF) Chickens against IBV and NDV Challenges
    Tan, Lei
    Wen, Guoyuan
    Qiu, Xusheng
    Yuan, Yanmei
    Meng, Chunchun
    Sun, Yingjie
    Liao, Ying
    Song, Cuiping
    Liu, Weiwei
    Shi, Yonghong
    Shao, Huabin
    Ding, Chan
    VACCINES, 2019, 7 (04)
  • [49] Construction of the First Russian Recombinant Live Attenuated Vaccine Strain and Evaluation of Its Protection Efficacy Against Two African Swine Fever Virus Heterologous Strains of Serotype 8
    Koltsov, Andrey
    Sukher, Mikhail
    Krutko, Sergey
    Belov, Sergey
    Korotin, Alexey
    Rudakova, Sofia
    Morgunov, Sergey
    Koltsova, Galina
    VACCINES, 2024, 12 (12)
  • [50] A Single-Dose Intramuscular Immunization of Pigs with Lipid Nanoparticle DNA Vaccines Based on the Hemagglutinin Antigen Confers Complete Protection against Challenge Infection with the Homologous Influenza Virus Strain
    Nguyen, The N.
    Kumari, Sushmita
    Sillman, Sarah
    Chaudhari, Jayeshbhai
    Lai, Danh C.
    Vu, Hiep L. X.
    VACCINES, 2023, 11 (10)